The mechanism for the reduced IFN signaling was investigated by measuring gene expression levels of components of the IFN signaling pathway including STAT2, JAK1, JAK2, and Tyk2, which were not significantly different between healthy donor and melanoma patient lymphocytes. This evidence concerns the gene IFNA1 and melanoma.